Results 261 to 270 of about 848,198 (341)

Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022: A repeated cross‐sectional study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Analgesic medicines are an important component of pain management, with different medicines carrying different risks and benefits. The aim of this study was to examine trends in analgesic prescribing in Ireland and England between 2014 and 2022. Methods Monthly data on medicines prescribed and dispensed in primary care were used. For Ireland, data
Molly Mattsson   +8 more
wiley   +1 more source

Therapeutic reasoning in case reports: Insights into current reporting and learning opportunities

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims While case reports can help to train diagnostic reasoning, will they improve therapeutic reasoning as well? Prescribing the right medication is difficult and prone to error, which can lead to patient harm. Therefore, good therapeutic reasoning skills are essential.
Mariëlle G. Hartjes   +5 more
wiley   +1 more source

Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis

open access: yesInternational Journal of Cancer, 2014
K. Hemminki   +5 more
semanticscholar   +1 more source

Lamivudine and tenofovir pharmacokinetic variability in people with HIV in Papua New Guinea

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Demographics and kidney function contribute to variability in lamivudine and tenofovir drug concentrations. The aim was to assess, for the first time, the pharmacokinetic variability of lamivudine and tenofovir in Papua New Guinean (PNG) HIV/AIDS patients.
Natália Bordin Andriguetti   +4 more
wiley   +1 more source

Adverse drug reactions, particularly liver disorders, drive interruptions in anti‐tuberculosis treatment: A retrospective cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a key driver of missed doses of anti‐tuberculosis (TB) therapy. We aimed to determine the relative burden of ADR‐driven missed doses, the missed dose patterns associated with ADRs, and the association between specific ADRs and missed doses.
Eleanor G. Dixon   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy